anti-B1 antibody Pages on BioPortfolio:

BioPortfolio - anti-B1 antibody
anti-B1 antibody - BioPortfolio. ... Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody for the Retreatment of Patients With Non-Hodgkin's Lymphoma .
...
http://www.bioportfolio.com/search/anti-B1_antibody_.html...

BioPortfolio - Radioimmunotherapy
Targeted monoclonal antibody therapy and radioimmunotherapy for ... Lymphoma Intervention: Radiation: 131Iodine-Anti-B1 Radioimmunotherapy ...
http://www.bioportfolio.com/indepth/Radioimmunotherapy.html...

BioPortfolio - fZD10 antibody therapy
Recent Search Terms used to find this page: frizzled | fZD10 antibody therapy | fZD10 antibody therapy | anti-B1 antibody | paul scherrer institute | . ...
http://www.bioportfolio.com/search/fZD10__antibody_therapy.h...

BioPortfolio - radil antibody
Radio immunotherapy utilizes an antibody labeled with a radionuclide to deliver ... BEAM+131I-Anti-B1 & Autologous Hematopoietic Stem Cell Transplant for . ...
http://www.bioportfolio.com/search/radil_antibody.html...

BioPortfolio - alexion antibody
2002]; Iodine-131 Tositumomab: (131)I-anti-B1 antibody, (131)I-tositumomab, anti -CD20 murine monoclonal ... http://www.ncbi.nlm.nih.gov/pubmed/12186261. ...
http://www.bioportfolio.com/search/alexion_antibody.html...

BioPortfolio - PRF
BioPortfolio I-131 anti-B1 antibody Antibody $554.00 HYB131-14 Mannan Binding Lectin (MBL), Clone: 131-14, ... Microsoft Word - Updated List of PRF/L .. ...
http://www.bioportfolio.com/search/PRF&L.html...

BioPortfolio - Retreatment
BioPortfolio - Retreatment trials ... http://www.bioportfolio. com/indepth/ Retreatment/trials.html... BioPortfolio - ap2b1 BioPortfolio - anti-B1 antibody
. ...
http://www.bioportfolio.com/search/Retreatment.html...

BioPortfolio - AP2B1
BioPortfolio - anti-B1 antibody BioPortfolio - AP2B1 - adaptor-related protein complex 2 ... http://www.bioportfolio.com/search/AP2B1.html. ...
http://www.bioportfolio.com/search/AP2B1.html...

BioPortfolio - 1997 annual report Coulter Pharmaceutical Inc
[14] I-131 labeled anti-CD20 antibody (anti-B1, Coulter Pharmaceutical Inc) was administered, followed by high-dose therapy (etoposide and cyclophosphamide) ...
http://www.bioportfolio.com/search/1997_annual_report__Coult...

BioPortfolio - Radioimmunotherapy
Targeted monoclonal antibody therapy and radioimmunotherapy for lymphoproliferative . ... 2005]; Iodine-131-anti-B1 radioimmunotherapy for B-
cell lymphoma. ...
http://www.bioportfolio.com/search/Radioimmunotherapy.html...

Results from other life science and pharmaceutical sites:

Low-Grade Non-Hodgkin's Lymphoma: A Year 2000 Perspective
The development of anti-B1, a murine anti-CD20 antibody, has paralleled the ... Like rituximab, the unconjugated anti-B1 antibody has been shown to induce ...
http://www.medscape.com/viewarticle/419087_8...

Use of radiolabeled monoclonal anti-B1 antibody fo...[Int J Rad ...
Studies were done in rhesus monkeys using radiolabeled monoclonal anti-B1 antibody to determine the feasibility of such an approach. ...
http://www.ncbi.nlm.nih.gov/pubmed/3298171...

Radiation Oncology: Radioimmunotherapy Clinical Trial #2
This is a single-arm, open-label, multi-center study of Iodine-131 Anti-B1 Antibody for the treatment of Non-Hodgkin's Lymphoma (NHL) patients who were ...
http://www.stanford.edu/group/RIT/trial2.html...

Iodine-131 Tositumomab: (131)I-anti-B1 antibody, (...[BioDrugs ...
Iodine-131 tositumomab [B1, Bexxar , iodine-131 anti-B1 antibody] is a murine antibody conjugated to iodine 131 that recognises and binds to the B1 (CD20) ...
http://www.ncbi.nlm.nih.gov/pubmed/12899647...

References
Patient specific radioimmunotherapy of non-Hodgkin's lymphoma with 131I-anti B1 antibody: pharmacokinetic dosing. Pharmacotherapy. 2000;20:352. ...
http://www.medscape.com/content/2002/00/43/66/436603/436603_...

Binding to CD20 by anti-B1 antibody or F(ab')(2) i...[Cancer ...
In this report we compared the activity of two anti-CD20 antibodies, Anti-B1 Antibody (tositumomab) and rituximab (C2B8), in a variety of cellular assays ...
http://www.ncbi.nlm.nih.gov/pubmed/11845256...

Radiation Therapy: Clinical Trials
Stanford/Coulter Pharmaceutical: Phase II Study of Iodine-131 Anti-B1 Antibody for Non-Hodgkin's Lymphoma Patients who have Previously Received Rituximab. ...
http://www.stanford.edu/group/RIT/...

Iodine-131 anti-B1 antibody for B-cell lymphoma: a...[J Nucl Med ...
Iodine-131 anti-B1 antibody radioimmunotherapy for B-cell lymphoma was previously reported to have substantial antitumor activity in B-cell non-
Hodgkin's ...
http://www.ncbi.nlm.nih.gov/pubmed/9708567...

HCI Clinical Trials List
CHOP + Iodine-131-Labeled Monoclonal Anti-B1 Antibody (Tositumomab) For Treatment of Newly Diagnosed Follicular Non-Hodgkin's Lymphomas" ...
http://www.hci.utah.edu/research/clinicalTrials~/trials/clin...

Outpatient treatment with (131)I-anti-B1 antibody:...[J Nucl Med ...
This article presents measured dose data for 26 family members exposed to 22 patients treated for non-Hodgkin's lymphoma with (131)I-anti-B1 antibody after
...
http://www.ncbi.nlm.nih.gov/pubmed/11390555...

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.